Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 48

1.

Runx-dependent and silencer-independent repression of a maturation enhancer in the Cd4 gene.

Kojo S, Yasmin N, Muroi S, Tenno M, Taniuchi I.

Nat Commun. 2018 Sep 5;9(1):3593. doi: 10.1038/s41467-018-05803-3.

2.

Data on the TGFβ response of CD4+ T cells in the absence of Eed.

Naito T, Muroi S, Taniuchi I, Kondo M.

Data Brief. 2018 Feb 17;17:1180-1183. doi: 10.1016/j.dib.2018.02.045. eCollection 2018 Apr.

3.

Requirement for intron structures in activating the Cd8a locus.

Wada H, Yasmin N, Kakugawa K, Ohno-Oishi M, Nieke S, Miyamoto C, Muroi S, Taniuchi I.

Proc Natl Acad Sci U S A. 2018 Mar 27;115(13):3440-3445. doi: 10.1073/pnas.1718837115. Epub 2018 Mar 12.

4.

Cbfβ2 controls differentiation of and confers homing capacity to prethymic progenitors.

Tenno M, Kojo S, Lawir DF, Hess I, Shiroguchi K, Ebihara T, Endo TA, Muroi S, Satoh R, Kawamoto H, Boehm T, Taniuchi I.

J Exp Med. 2018 Feb 5;215(2):595-610. doi: 10.1084/jem.20171221. Epub 2018 Jan 17.

5.

Loss of Eed leads to lineage instability and increased CD8 expression of mouse CD4+ T cells upon TGFβ signaling.

Naito T, Muroi S, Taniuchi I, Kondo M.

Mol Immunol. 2018 Feb;94:140-152. doi: 10.1016/j.molimm.2017.12.021. Epub 2018 Jan 5.

PMID:
29310022
6.

Unique N-terminal sequences in two Runx1 isoforms are dispensable for Runx1 function.

Nieke S, Yasmin N, Kakugawa K, Yokomizo T, Muroi S, Taniuchi I.

BMC Dev Biol. 2017 Oct 18;17(1):14. doi: 10.1186/s12861-017-0156-y.

7.

Priming of lineage-specifying genes by Bcl11b is required for lineage choice in post-selection thymocytes.

Kojo S, Tanaka H, Endo TA, Muroi S, Liu Y, Seo W, Tenno M, Kakugawa K, Naoe Y, Nair K, Moro K, Katsuragi Y, Kanai A, Inaba T, Egawa T, Venkatesh B, Minoda A, Kominami R, Taniuchi I.

Nat Commun. 2017 Sep 26;8(1):702. doi: 10.1038/s41467-017-00768-1.

8.

Cbfβ2 deficiency preserves Langerhans cell precursors by lack of selective TGFβ receptor signaling.

Tenno M, Shiroguchi K, Muroi S, Kawakami E, Koseki K, Kryukov K, Imanishi T, Ginhoux F, Taniuchi I.

J Exp Med. 2017 Oct 2;214(10):2933-2946. doi: 10.1084/jem.20170729. Epub 2017 Aug 16.

9.

Essential Roles of SATB1 in Specifying T Lymphocyte Subsets.

Kakugawa K, Kojo S, Tanaka H, Seo W, Endo TA, Kitagawa Y, Muroi S, Tenno M, Yasmin N, Kohwi Y, Sakaguchi S, Kowhi-Shigematsu T, Taniuchi I.

Cell Rep. 2017 May 9;19(6):1176-1188. doi: 10.1016/j.celrep.2017.04.038.

10.

Osteochondritis Dissecans of the Humeral Capitellum in Young Athletes: Comparison Between Baseball Players and Gymnasts.

Kajiyama S, Muroi S, Sugaya H, Takahashi N, Matsuki K, Kawai N, Osaki M.

Orthop J Sports Med. 2017 Mar 1;5(3):2325967117692513. doi: 10.1177/2325967117692513. eCollection 2017 Mar.

11.

Distinct requirement of Runx complexes for TCRβ enhancer activation at distinct developmental stages.

Seo W, Muroi S, Akiyama K, Taniuchi I.

Sci Rep. 2017 Feb 2;7:41351. doi: 10.1038/srep41351.

12.

Epigenetic Thpok silencing limits the time window to choose CD4(+) helper-lineage fate in the thymus.

Tanaka H, Naito T, Muroi S, Seo W, Chihara R, Miyamoto C, Kominami R, Taniuchi I.

EMBO J. 2013 Apr 17;32(8):1183-94. doi: 10.1038/emboj.2013.47. Epub 2013 Mar 12.

13.

Transcriptional reprogramming of mature CD4⁺ helper T cells generates distinct MHC class II-restricted cytotoxic T lymphocytes.

Mucida D, Husain MM, Muroi S, van Wijk F, Shinnakasu R, Naoe Y, Reis BS, Huang Y, Lambolez F, Docherty M, Attinger A, Shui JW, Kim G, Lena CJ, Sakaguchi S, Miyamoto C, Wang P, Atarashi K, Park Y, Nakayama T, Honda K, Ellmeier W, Kronenberg M, Taniuchi I, Cheroutre H.

Nat Immunol. 2013 Mar;14(3):281-9. doi: 10.1038/ni.2523. Epub 2013 Jan 20.

14.

Cutting edge: fine-tuning of Thpok gene activation by an enhancer in close proximity to its own silencer.

Muroi S, Tanaka H, Miyamoto C, Taniuchi I.

J Immunol. 2013 Feb 15;190(4):1397-401. doi: 10.4049/jimmunol.1203006. Epub 2013 Jan 11.

15.

Identification and analysis of an early diagnostic marker for malignant melanoma: ZAR1 intra-genic differential methylation.

Shinojima Y, Terui T, Hara H, Kimura M, Igarashi J, Wang X, Kawashima H, Kobayashi Y, Muroi S, Hayakawa S, Esumi M, Fujiwara K, Ghosh S, Yamamoto T, Held W, Nagase H.

J Dermatol Sci. 2010 Aug;59(2):98-106. doi: 10.1016/j.jdermsci.2010.04.016. Epub 2010 May 20.

16.

Nonredundant roles for Runx1 alternative promoters reflect their activity at discrete stages of developmental hematopoiesis.

Bee T, Swiers G, Muroi S, Pozner A, Nottingham W, Santos AC, Li PS, Taniuchi I, de Bruijn MF.

Blood. 2010 Apr 15;115(15):3042-50. doi: 10.1182/blood-2009-08-238626. Epub 2010 Feb 4.

17.

Quantitative analysis of human tissue-specific differences in methylation.

Igarashi J, Muroi S, Kawashima H, Wang X, Shinojima Y, Kitamura E, Oinuma T, Nemoto N, Song F, Ghosh S, Held WA, Nagase H.

Biochem Biophys Res Commun. 2008 Nov 28;376(4):658-64. doi: 10.1016/j.bbrc.2008.09.044. Epub 2008 Sep 19.

18.

Cascading suppression of transcriptional silencers by ThPOK seals helper T cell fate.

Muroi S, Naoe Y, Miyamoto C, Akiyama K, Ikawa T, Masuda K, Kawamoto H, Taniuchi I.

Nat Immunol. 2008 Oct;9(10):1113-21. doi: 10.1038/ni.1650. Epub 2008 Sep 7.

PMID:
18776907
19.

Phosphorylation of Runx1 at Ser249, Ser266, and Ser276 is dispensable for bone marrow hematopoiesis and thymocyte differentiation.

Tachibana M, Tezuka C, Muroi S, Nishimoto S, Katsumoto T, Nakajima A, Kitabayashi I, Taniuchi I.

Biochem Biophys Res Commun. 2008 Apr 11;368(3):536-42. doi: 10.1016/j.bbrc.2008.01.124. Epub 2008 Feb 6.

PMID:
18261462
20.

Repression of the transcription factor Th-POK by Runx complexes in cytotoxic T cell development.

Setoguchi R, Tachibana M, Naoe Y, Muroi S, Akiyama K, Tezuka C, Okuda T, Taniuchi I.

Science. 2008 Feb 8;319(5864):822-5. doi: 10.1126/science.1151844.

21.

Repression of interleukin-4 in T helper type 1 cells by Runx/Cbf beta binding to the Il4 silencer.

Naoe Y, Setoguchi R, Akiyama K, Muroi S, Kuroda M, Hatam F, Littman DR, Taniuchi I.

J Exp Med. 2007 Aug 6;204(8):1749-55. Epub 2007 Jul 23.

22.

Selective determination of surface density of bromide ion through XAFS and its application to verification of a criterion of an ideal mixing of surfactant mixture.

Aratono M, Kashimoto K, Matsuda T, Muroi S, Takata Y, Ikeda N, Takiue T, Tanida H, Watanabe I.

Langmuir. 2005 Aug 2;21(16):7398-404.

PMID:
16042471
23.

Embolic attack in patients with atrial fibrillation and atrial thrombus depends on the character of the thrombus.

Abe Y, Asakura T, Sakamoto N, Ishikawa S, Muroi S, Saitoh F, Satoh M, Suzuki S, Ono M, Sakabe A, Iwai M, Sando M, Gotou J, Watanabe Y, Nagata K, Maehara K, Maruyama Y.

Circ J. 2003 Mar;67(3):203-8.

24.

Molecular cloning, mRNA expression and chromosomal localization of mouse angiotensin-converting enzyme-related carboxypeptidase (mACE2).

Komatsu T, Suzuki Y, Imai J, Sugano S, Hida M, Tanigami A, Muroi S, Yamada Y, Hanaoka K.

DNA Seq. 2002 Aug;13(4):217-20.

PMID:
12487024
25.
26.

Influence of vitamin E on platelet survival.

Uchida T, Muroi S, Yui T, Hiraguri M, Yanagisawa S, Umezu H, Kariyone S.

Tohoku J Exp Med. 1985 Dec;147(4):342-8.

27.

[Determination of blood platelet survival].

Yui T, Muroi S.

Rinsho Byori. 1985 Apr;Spec No 62:32-45. Review. Japanese. No abstract available.

PMID:
3928949
28.

[A family study of storage pool disease].

Yanagisawa S, Uchida T, Muroi S, Yui T, Shichishima T, Suzuki T, Matsuda S, Yoshida H, Kariyone S.

Rinsho Ketsueki. 1984 Feb;25(2):217-24. Japanese. No abstract available.

PMID:
6471432
29.

[Antiplatelet therapy in mitral stenosis].

Muroi S.

J Cardiogr. 1983 Mar;13(1):211. Japanese. No abstract available.

PMID:
6644117
30.

[Study on the knowledge of diabetic patients and the extent of their disease control].

Okoda M, Kamijo H, Shimada A, Muroi S, Yamamoto C.

Kangogaku Zasshi. 1982 Sep;46(9):1029-36. Japanese. No abstract available.

PMID:
6922994
31.

Quantitative estimation of the right ventricular overloading by thallium-201 myocardial scintigraphy.

Owada K, Machii K, Tsukahara Y, Awano N, Kijima M, Miyazaki Y, Ono K, Ebitani S, Muroi S, Ikeda K, Uchida T, Kariyone S.

Jpn Circ J. 1982 Jul;46(7):715-24.

PMID:
7097976
32.

[Detection of intracardiac thrombi by scintiphotography with 111-In labeled autologous platelets (author's transl)].

Yui T, Uchida T, Matsuda S, Muroi S, Sato M, Kijima M, Ebitani S, Iwaya K, Machii K, Kariyone S, Iwaya F, Hoshino S.

Kokyu To Junkan. 1982 Apr;30(4):401-10. Japanese. No abstract available.

PMID:
7100683
33.

Detection of platelet consumption in aortic graft with 111In-labeled platelets.

Yui T, Uchida T, Matsuda S, Iwaya K, Umino M, Ono K, Muroi S, Owada K, Machii K, Kariyone S.

Eur J Nucl Med. 1982;7(2):77-9.

PMID:
6211359
34.

[Prevalence and causes of iron deficiency in Japanese women (author's transl)].

Uchida T, Tanaka T, Umino M, Shichishima T, Kokubun R, Yui T, Kimura H, Muroi S, Matsuda S, Kariyone S.

Nihon Naika Gakkai Zasshi. 1981 Oct 10;70(10):1401-7. Japanese. No abstract available.

PMID:
7328359
35.

[Clinical evaluation of cefotiam in internal medicine, with special reference to infectious disease associated with hematological disorders (author's transl)].

Uchida T, Matsuda S, Tanaka T, Muroi S, Kimura H, Satoh T, Yui T, Satoh S, Fujino A, Mita M, Yamada Z, Kariyone S, Yoshida H, Kikuta T, Miura N, Itoh K, Ikeda K, Nemoto T, Hiraguri M, Sanbe M, Takezawa M, Nakamura Y, Satoh Y, Funayama S, Igarashi T, Ogiu A, Maseki N, Komatsu M.

Jpn J Antibiot. 1981 Aug;34(8):1148-57. Japanese.

PMID:
6275142
36.

[Basic study of platelet labeling with 111In-oxine (author's transl)].

Yui T, Uchida T, Matsuda S, Muroi S, Tanaka T, Saito M, Kariyone S.

Kaku Igaku. 1981 May;18(4):463-72. Japanese. No abstract available.

PMID:
6793757
37.

Red cell production and destruction in primary myelofibrosis with reference to the neutrophil and platelet kinetics.

Uchida T, Umino M, Yui T, Kimura H, Tanaka T, Muroi S, Matsuda S, Kariyone S.

Nihon Ketsueki Gakkai Zasshi. 1981 Feb;44(1):31-6. No abstract available.

PMID:
7315143
38.

Red cell production and destruction in chronic myelocytic leukemia with reference to the neutrophil kinetics.

Uchida T, Kokubun R, Yui T, Kimura H, Muroi S, Tanaka T, Matsuda S, Yoshida H, Kariyone S.

Nihon Ketsueki Gakkai Zasshi. 1981 Feb;44(1):24-30. No abstract available.

PMID:
7315142
39.

[Evaluation of the myocardial infarct size using thallium-201 scintiphotography (author's transl)].

Owada K, Machii K, Tsukahara Y, Abe H, Ono K, Ebitani S, Muroi S, Iwaya K, Ikeda K, Uchida T, Kariyone S, Kida T.

Kokyu To Junkan. 1981 Feb;29(2):185-93. Japanese. No abstract available.

PMID:
7255972
40.

[Clinical studies on the thallium-201 myocardial scintiphotography in the patients with ischemic heart diseases: studies in organ distribution of thallium-201 and in the measurement of myocardial blood flow (author's transl)].

Owada K, Tsukahara Y, Abe H, Ono K, Ebitani S, Muroi S, Matsuda S, Ikeda K, Machii K, Uchida T, Kida T, Kariyone S.

Kaku Igaku. 1980 Sep;17(8):891-9. Japanese. No abstract available.

PMID:
7218585
41.

[A case of chronic myelocytic leukemia (CML) with terminal manifestation of acute promyelocytic leukemia (author's transl)].

Matsuda S, Igarashi T, Kimura H, Muroi S, Tanaka T, Uchida T, Kariyone S.

Rinsho Ketsueki. 1980 Sep;21(9):1401-7. Japanese. No abstract available.

PMID:
6935450
42.

[The points at issue in stress electrocardiogram (author's transl)].

Machii K, Ikeda K, Owada K, Iwaya K, Ebitani S, Muroi S, Ono K, Abe H, Kariyone S, Abe K.

Rinsho Byori. 1979 Oct;27(10):914-20. Japanese. No abstract available.

PMID:
533912
43.

Shortened platelet survival in acute promyelocytic leukemia.

Uchida T, Yui T, Muroi S, Kariyone S.

Tohoku J Exp Med. 1979 Oct;129(2):205-6.

44.

[Blood cell labelling with technetium-99m (6). In vitro studies of platelet labelling by 99mTc and clinical application (author's transl)].

Yui T, Uchida T, Muroi S, Matsuda S, Akizuki T, Saito M, Kida T, Kariyone S.

Kaku Igaku. 1979 Aug;16(5):685-93. Japanese. No abstract available.

PMID:
537234
45.

Cycloscopy of pseudoexfoliation.

Mizuno K, Muroi S.

Am J Ophthalmol. 1979 Apr;87(4):513-8.

PMID:
443315
46.

Cycloscopy of angle-closure glaucoma.

Mizuno K, Kimura R, Muroi S.

Albrecht Von Graefes Arch Klin Exp Ophthalmol. 1977 Dec 31;204(4):247-54.

PMID:
304683
47.

Cycloscopy and fluorescein cycloscopy of the ciliary process.

Mizuno K, Asaoka M, Muroi S.

Am J Ophthalmol. 1977 Oct;84(4):487-95.

PMID:
910852
48.

[Cycloscopy and fluorescein cycloscopy. 2. Fundamental study of fluorescein cycloscopy (author's transl)].

Asaoka M, Muroi S, Mizuno K.

Nippon Ganka Gakkai Zasshi. 1976 Oct;80(10):1062-70. Japanese. No abstract available.

PMID:
1034404

Supplemental Content

Support Center